8-2-2022: Chengdu, China: "genetic screening is needed for fetuses with autoimmune antibody-negative, high-degree AVBlock, especially those with 2:1 AVB and in those cases in which changes in fetal heart rhythm occur with initial dexamethasone treatment"
Case Report: A novel KNCH2 variant-induced fetal heart block and the advantages of fetal genomic sequencing in prenatal long-term dexamethasone exposure. https://t.co/NtqnZu5rzd #longqt #cardiotwitter #epeeps
Case Report: A novel KNCH2 variant-induced fetal heart block and the advantages of fetal genomic sequencing in prenatal long-term dexamethasone exposure https://t.co/lLZZNvrkQH Frontiers in genetics
New Research: Case Report: A novel KNCH2 variant-induced fetal heart block and the advantages of fetal genomic sequencing in prenatal long-term dexamethasone exposure: Background: Fetal bradycardia is a common but severe condition. In addition… https://t.c